Publications

Showing

0

out of

0

results

Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber's optic neuropathy and multiple sclerosis - a case report.

Holmøy T, Beiske AG, Zarnovicky S,

October 17, 2016

Reperfusion therapy in stroke cases with unknown onset.

Rønning OM.

September 12, 2016

Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.

van Steenoven I, Aarsland D,

August 17, 2016

Family planning, pregnancy and breastfeeding in multiple sclerosis.

Holmøy T, Torkildsen Ø.

August 10, 2016

No association of tobacco use and disease activity in multiple sclerosis.

Kvistad S, Myhr KM, Holmøy T,

July 13, 2016

Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease.

Tajeddinn W, Persson T, Calvo-Garrido J,

July 4, 2016

Evolution of clinical features in possible DLB depending on FP-CIT SPECT result.

Walker Z, Moreno E, Thomas A,

June 8, 2016

Altered DNA base excision repair profile in brain tissue and blood in Alzheimer's disease.

Lillenes MS, Rabano A, Støen M,

May 27, 2016

Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study.

Simonsen CS, Celius EG, Brunborg C,

May 11, 2016

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease.

Henjum K, Almdahl IS, Årskog V,

April 26, 2016